Definium Therapeutics, Inc. - Common Shares, no par value per share (DFTX)

Q: What does CUSIP 24477V105 represent in this 13F holders report?

CUSIP 24477V105 is the security identifier for DFTX - Definium Therapeutics, Inc. - Common Shares, no par value per share used to aggregate holder disclosures.

Q: How many institutions held DFTX - Definium Therapeutics, Inc. - Common Shares, no par value per share in Q4 2025?

8 institutional investors reported DFTX - Definium Therapeutics, Inc. - Common Shares, no par value per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 24477V105

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Shares, no par value per share
Shares outstanding: 103,177,431
Total 13F shares: 11,252,538
Share change: +11,252,147
Total reported value: $150,679,840
Price per share: $13.39
Number of holders: 8
Value change: +$150,673,017
Number of buys: 7

Quarterly Holders Quick Answers

What is CUSIP 24477V105?
CUSIP 24477V105 identifies DFTX - Definium Therapeutics, Inc. - Common Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026

Recent filing periods for CUSIP 24477V105:

Q1 2026 Q4 2025

Top shareholders of DFTX - Definium Therapeutics, Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock, Inc.	13F 13D/G	Company	8.3% from 13D/G	5,935,557	$69,980,216	—	30 Sep 2025	13F 13D/G
Stephen L. Hurst	3/4/5	Director, Former Director	— class O/S missing	40,722,778	$47,645,650	—	05 Jan 2022	3/4/5
Commodore Capital LP	13F 13D/G	Company	7.2% from 13D/G	3,225,000	$38,022,750	—	30 Sep 2025	13F 13D/G
DRIEHAUS CAPITAL MANAGEMENT LLC	13F 13D/G	Company	6.6% from 13D/G	3,109,911	$36,665,851	—	30 Sep 2025	13F 13D/G
Blackstone Inc.	13F	Company	3.5%	2,776,561	$32,735,654	—	30 Sep 2025	13F
MARSHALL WACE, LLP	13F	Company	3%	2,381,980	$28,083,543	—	30 Sep 2025	13F
Octagon Capital Advisors LP	13F	Company	2.7%	2,130,000	$25,112,700	—	30 Sep 2025	13F
VANGUARD GROUP INC	13F	Company	2.5%	2,012,874	$23,731,784	—	30 Sep 2025	13F
STATE STREET CORP	13F	Company	2.4%	1,924,893	$22,694,488	—	30 Sep 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.3%	1,824,701	$21,516,698	—	30 Sep 2025	13F
Deep Track Capital, LP	13F 13D/G	Company	5.5% from 13D/G	1,500,000	$17,685,000	—	30 Sep 2025	13F 13D/G
AWM Investment Company, Inc.	13F	Company	1.5%	1,215,662	$14,332,655	—	30 Sep 2025	13F
Rosalind Advisors, Inc.	13F	Company	0.94%	750,000	$8,842,500	—	30 Sep 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.79%	633,702	$7,471,347	—	30 Sep 2025	13F
NORTHERN TRUST CORP	13F	Company	0.79%	628,538	$7,410,463	—	30 Sep 2025	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.75%	600,200	$7,076,358	—	30 Sep 2025	13F
UBS Group AG	13F	Company	0.69%	551,809	$6,505,829	—	30 Sep 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.69%	550,630	$6,491,928	—	30 Sep 2025	13F
MORGAN STANLEY	13F	Company	0.62%	495,618	$5,843,338	—	30 Sep 2025	13F
ORBIMED ADVISORS LLC	13F	Company	0.46%	367,824	$4,336,645	—	30 Sep 2025	13F
Ally Bridge Group (NY) LLC	13F	Company	0.45%	361,444	$4,261,425	—	30 Sep 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.42%	339,438	$4,001,974	—	30 Sep 2025	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.37%	300,000	$3,537,000	—	30 Sep 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.37%	298,205	$3,515,837	—	30 Sep 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.37%	296,443	$3,495,063	—	30 Sep 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.34%	274,848	$3,240,458	—	30 Sep 2025	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.32%	256,366	$3,022,555	—	30 Sep 2025	13F
Nuveen, LLC	13F	Company	0.29%	233,504	$2,753,012	—	30 Sep 2025	13F
Bank of New York Mellon Corp	13F	Company	0.29%	229,031	$2,700,274	—	30 Sep 2025	13F
Point72 Asset Management, L.P.	13F	Company	0.28%	224,300	$2,644,497	—	30 Sep 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	0.27%	216,334	$2,550,578	—	30 Sep 2025	13F
Schond L. Greenway	3/4/5	Chief Financial Officer	— mixed-class rows	361,057 mixed-class rows	$2,064,137	—	25 Mar 2024	3/4/5
Boxer Capital Management, LLC	13F	Company	0.2%	163,500	$1,927,665	—	30 Sep 2025	13F
CenterBook Partners LP	13F	Company	0.2%	159,421	$1,879,574	—	30 Sep 2025	13F
BARCLAYS PLC	13F	Company	0.19%	150,605	$1,775,634	—	30 Sep 2025	13F
AdvisorShares Investments LLC	13F	Company	0.15%	121,664	$1,434,419	—	30 Sep 2025	13F
Cynthia W. Hu	3/4/5	Chief Legal Officer&Secretary	— mixed-class rows	2,760,000 mixed-class rows	$1,404,000	—	24 Mar 2022	3/4/5
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.15%	117,239	$1,382,248	—	30 Sep 2025	13F
Swiss National Bank	13F	Company	0.15%	117,100	$1,380,609	—	30 Sep 2025	13F
RHUMBLINE ADVISERS	13F	Company	0.14%	112,118	$1,321,859	—	30 Sep 2025	13F
Cubist Systematic Strategies, LLC	13F	Company	0.14%	108,214	$1,275,843	—	30 Sep 2025	13F
Miri Halperin Wernli	3/4/5	Executive President	— class O/S missing	202,405	$1,248,839	—	21 Aug 2024	3/4/5
DIADEMA PARTNERS LP	13F	Company	0.13%	105,891	$1,248,455	—	30 Sep 2025	13F
Data Collective IV GP, LLC	13F	Company	0.13%	100,350	$1,183,127	—	30 Sep 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.1%	84,011	$990,490	—	30 Sep 2025	13F
Carrie Liao	3/4/5	Chief Accounting Officer	— class O/S missing	144,923	$976,781	—	25 Mar 2025	3/4/5
TWO SIGMA ADVISERS, LP	13F	Company	0.1%	81,483	$960,685	—	30 Sep 2025	13F
ROYCE & ASSOCIATES LP	13F	Company	0.1%	81,024	$955,273	—	30 Sep 2025	13F
STEMPOINT CAPITAL LP	13F	Company	0.1%	76,875	$906,356	—	30 Sep 2025	13F
LPL Financial LLC	13F	Company	0.09%	75,947	$895,415	—	30 Sep 2025	13F

Institutional Holders of Definium Therapeutics, Inc. - Common Shares, no par value per share (DFTX) as of Q4 2025

As of 31 Dec 2025, Definium Therapeutics, Inc. - Common Shares, no par value per share (DFTX) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,252,538 shares. The largest 8 holders included Driehaus Capital Management LLC, MARSHALL WACE, LLP, AWM Investment Company, Inc., Ensign Peak Advisors, Inc, PRICE T ROWE ASSOCIATES INC /MD/, DARK FOREST CAPITAL MANAGEMENT LP, Sound Income Strategies, LLC, and Sankala Group LLC. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q4 2025 Across Filers

Q4 2025 holders

Holder diff

Investor	Q4 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.